TLRs: Professor Mechnikov, sit on your hat

Trends in Immunology

Volumn 25, Issue 12, 2004, Pages 687-693

  O'Neill, Luke A J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; MURAMYL DIPEPTIDE; PYROGEN; RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR; VACCINE;

B LYMPHOCYTE; DENDRITIC CELL; GENE EXPRESSION; HOST RESISTANCE; HUMAN; IMMUNITY; INFLAMMATION; INFLAMMATORY DISEASE; LIFE EVENT; MEMORY CELL; NONHUMAN; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL;

ALLERGY AND IMMUNOLOGY; ANIMALS; GENE EXPRESSION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOLOGIC MEMORY; INFECTION; MEMBRANE GLYCOPROTEINS; MICE; MODELS, IMMUNOLOGICAL; PYROGENS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 7644240681     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2004.10.005     Document Type: Review

References (68)

1. Mitchison, A. (September1993) Will we survive? Scientific American 269, 136-144
2. Janeway, C.A. (September 1993) How the immune system recognizes invaders. Scientific American 269, 73-79
3. I.L. Bennett, and P.B. Beeson Studies on the pathogenesis of fever. Characterisation of fever-producing substances from polymorphonuclear leukocytes and from the fluid of sterile exudates J. Exp. Med. 98 1953 493 508
4. J.E. Sims cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily Science 241 1988 585 589
5. N.J. Gay, and F. Keith Drosophila Toll and IL-1 receptor Nature 351 1991 355 356
6. D. St Johnston, and C. Nusslein-Volhard The origin of pattern and polarity in the Drosophila embryo Cell 68 1992 201 219
7. L. Osborn Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB Proc. Natl. Acad. Sci. U. S. A. 86 1989 2336 2340
8. S.C. Sun Stucture and expression of the attacin genes in Hyalophora cecropia Eur. J. Biochem. 196 1991 247 254
9. B. Lemaitre The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults Cell 86 1996 973 983
10. S. Whitham The product of the Tobacco Mosaic virus resistance gene N: similarity to Toll and the interleukin-1 receptor Cell 78 1994 1101 1115
11. B. Baker Signaling in plant-microbe interactions Science 276 1997 726 733
12. R. Medzhitov A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 388 1997 394 397
13. F.L. Rock A family of human receptors structurally related to Drosophila Toll Proc. Natl. Acad. Sci. U. S. A. 95 1998 588 593
14. L.A.J. O'Neill, and C. Greene Signal transduction pathways activated by the IL-1 receptor family: ancient signalling machinery in mammals, insects and plants J. Leukoc. Biol. 63 1998 650 657
15. R.B. Yang Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling Nature 395 1998 284 288
16. A. Poltorak Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in the TLR4 gene Science 282 1998 2085 2088
17. S.T. Qureshi Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) J. Exp. Med. 189 1999 615 625
18. J.C. Chow Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction J. Biol. Chem. 274 1999 10689 10692
19. H.D. Brightbill Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors Science 285 1999 732 735
20. A.O. Aliprantis Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2 Science 285 1999 736 739
21. D.M. Underhill The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens Nature 401 1999 811 815
22. C.A. Shelton, and S.A. Wasserman pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo Cell 72 1993 515 525
23. Z. Cao IRAK: a kinase associated with the interleukin-1 receptor Science 271 1996 1128 1131
24. H. Wesche MyD88: an adapter that recruits IRAK to the IL-1 receptor complex Immunity 7 1997 837 847
25. K.A. Lord Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6 Oncogene 5 1990 1095 1097
26. O. Takeuchi Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signalling cascades Int. Immunol. 12 2000 113 117
27. T. Kawai Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of interferon-regulatory factor 3 and the expression of a subset of lipopolysaccharide inducible genes J. Immunol. 167 2001 5887 5894
28. K.A. Fitzgerald Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction Nature 413 2001 78 83
29. T. Horng TIRAP: an adapter molecule in the Toll signaling pathway Nat. Immunol. 2 2001 835 841
30. M. Yamamoto Cutting edge: a novel Toll/Il-1 receptor domain - containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signalling J. Immunol. 169 2002 6668 6672
31. H. Oshiumi TICAM-1, an adapter molecule that participates in Toll-like receptor 3-mdeiated interferon-β induction Nat. Immunol. 4 2003 161 171
32. K. Hoebe Identification of Lps2 as a key transducer of MyD88-independent TIR signalling Nature 424 2003 743 748
33. K.A. Fitzgerald LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the Toll adapters TRAM and TRIF J. Exp. Med. 198 2003 1043 1055
34. M. Yamamoto TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway Nat. Immunol. 4 2003 1144 1150
35. N.C. Arbour TLR4 mutations are associated with endotoxin hyporesponsiveness in humans Nat. Genet. 25 2000 187 191
36. S. Kiechl Toll-like receptor 4 polymorphisms and atherogenesis N. Engl. J. Med. 347 2002 185 192
37. T.R. Hawn A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease J. Exp. Med. 198 2003 1563 1572
38. A.E. Medvedev Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections J. Exp. Med. 198 2003 521 531
39. C. Picard Pyogenic bacterial infections in humans with IRAK-4 deficiency Science 299 2003 2076 2079
40. R.L. Reinhardt Visualizing the generation of memory CD4 T cells in the whole body Nature 410 2001 101 105
41. K. Hoebe Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways Nat. Immunol. 4 2003 1223 1229
42. Q. Huang The plasticity of dendritic cell responses to pathogens and their components Science 294 2001 870 875
43. O. Takeuchi, and S. Akira Genetic approaches to the study of Toll-like receptor function Microbes Infect. 4 2002 887 895
44. O. Takeuchi, and S. Akira Genetic approaches to the study of Toll-like receptor function Microbes Infect. 4 2002 887 895
45. D.M. Underhill Toll-like receptors and microbes take aim at each other Curr. Opin. Immunol. 16 2004 483 487
46. F. Backhed Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor-4 J. Infect. Dis. 187 2003 829 836
47. B.W. Bainbridge, and R.P. Darveau Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system Acta Odontol. Scand. 59 2001 131 138
48. A. Bowie A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling Proc. Natl. Acad. Sci. U. S. A. 97 2000 10162 10167
49. M.T. Harte The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense J. Exp. Med. 197 2003 343 351
50. Z. Pancer Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey Nature 430 2004 174 180
51. S. Akira, and K. Takeda Toll-like receptor signalling Nat. Rev. Immunol. 4 2004 499 511
52. D. Wald SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling Nat. Immunol. 4 2003 920 927
53. E.K. Brint ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance Nat Immunol. 5 2004 373 379
54. S. Janssens Regulation of interleukin-1- and lipopolysaccharide-induced NF-κB activation by alternative splicing of MyD88 Curr Biol. 12 2002 467 471
55. M. Hardy, and L.A. O'Neill The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory J. Biol. Chem. 279 2004 27699 27708
56. K. Kobyashi IRAK-M is a negative regulator of Toll-like receptor signaling Cell 110 2002 191 202
57. I. Kinjyo SOCS1/JAB is a negative regulator of LPS-induced macrophage activation Immunity 17 2002 583 591
58. T. Watanabe NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper 1 responses Nature Immunol. 2004
59. S.E. Girardin NOD2 is a general sensor of peptidoglycan through muramyl dipeptide detection J. Biol. Chem. 278 2003 8869 8872
60. J.P. Hugot Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599 603
61. L.A. O'Neill Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases Curr. Opin. Pharmacol. 3 2003 396 403
62. R.J. Ulevitch Therapeutics targeting the innate immune system Nat. Rev. Immunol. 4 2004 512 520
63. th, 1908. http://www.nobel.se/medicine/laureates/1908/mechnikov-lecture.html
64. S. Sharma Triggering the interferon antiviral response through an IKK-related pathway Science 300 2003 1148 1151
65. K.A. Fitzgerald IKKε and TBK-1 are essential components of the IRF3 signalling pathway Nat. Immunol. 4 2003 491 496
66. S.H. Ridley Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels J. Immunol. 158 1997 3165 3173
67. S. Rivest What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies Mol Psychiatry. 4 1999 500 507
68. N. Inohara, and G. Nunez NODs: intracellular proteins involved in inflammation and apoptosis Nat. Rev. Immunol. 3 2003 371 382